Navy Medical Center Portsmouth
Psychiatry
Dr. Miranda Chakos, MD
|
|
Give Review
Miranda Chakos practices Psychiatry. She studied medicine at State University of New York Upstate Medical University. Miranda Chakos, MD is a published doctor. She published 51 publications, including: 'Serotonergic basis of antipsychotic drug effects in schizophrenia.'
Publications
- Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.
- Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
- Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
- Extrapyramidal side-effects of antipsychotics in a randomised trial.
- Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder.
- Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics.
- Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.
- Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.
- The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.
- Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia.
- Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects.
- Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
- Secretin for refractory schizophrenia.
- Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
- Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
- Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
- Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
- Antipsychotic-induced weight gain and therapeutic response: a differential association.
- Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
- The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches.
- Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
- Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial.
- Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
- Longitudinal study of brain morphology in first episode schizophrenia.
- IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness.
- Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum.
- Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.
- Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.
- Serotonergic basis of antipsychotic drug effects in schizophrenia.
- Striatal enlargement in rats chronically treated with neuroleptic.
- The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective.
- Emerging roles for novel antipsychotic medications in the treatment of schizophrenia.
- Clinical applications of neuroimaging in psychiatry.
- The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controls.
- Psychobiologic correlates of treatment response in schizophrenia.
- Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia.
- Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
- Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
- Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.
- Depression in first-episode schizophrenia.
- Cerebral morphometry and clozapine treatment in schizophrenia.
- Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.
- Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effects.
- Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.
- Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: preliminary findings.
- Syncope associated with the combination of clozapine and enalapril.
- Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine.
- Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
- Real-life basis for a patient's paranoia.
- Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia.
Schools
Upstate Medical University College of Health Professions
Menninger Fdn
Stony Brook University Hospital
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
SUNY Stony Brook University Hospital & Medical Center -
State University of New York Upstate Medical University
Helpful Reviews
Similar Doctors
|
|
Dr. Gemma Guillermo, MD |
|
|
Dr. Cheryl H. Cottrol, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melanie E. Spritz, DO |
|
|
Dr. Sanyup J. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan W. Stewart, MD |
|
|
Dr. Ali M. Ahmed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ayodeji I. Jolayemi, MD |
|
|
Dr. Matthew M. Schiff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marian Moca, MD
This Doctor is OpenDoctor Recommended.
|